The global nephrology devices market accounted for $12,012 XX million in 2018, and is expected to reach $16,421 XX million by 2026, registering a CAGR of XX4.0% from 2019 to 2026

Ads

You May Also Like

VBL Therapeutics to Report Second Quarter 2017 Results on August 14

TEL AVIV, Israel, Aug. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018

SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), ...

Vedantra Pharmaceuticals Names Gregory I. Berk President and Chief Medical Officer

CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company ...